Taking into account the outcome of the exposure assessment published by the Authority on 10 August 2017, the applicant revised again the proposed uses and uses levels for bixin and norbixin, and submitted to the Commission on 20 July 2018 three alternative scenarios of uses and use levels.
Recital 15, Regulation (EU) 2020/771
In forcesince 11 Jun 2020